Cisapride Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Cisapride Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cisapride
Brand name: Propulsid
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisapride Tablets-Insulin degludec
- Cisapride Tablets-Insulin Degludec (U-100) Prefilled Pens
- Cisapride Tablets-Insulin Degludec (U-100) Vials
- Cisapride Tablets-Insulin Degludec (U-200) Prefilled Pens
- Cisapride Tablets-Insulin degludec and liraglutide
- Cisapride Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cisatracurium
- Insulin aspart, recombinant Subcutaneous-Cisatracurium Besylate
- Insulin aspart, recombinant Subcutaneous-Cisatracurium Besylate Injection
- Insulin aspart, recombinant Subcutaneous-Cisatracurium besylate Intravenous
- Insulin aspart, recombinant Subcutaneous-Cisplatin
- Insulin aspart, recombinant Subcutaneous-Cisplatin Intravenous